Back
Docebo Vs. Keros Therapeutics Industry Stock Comparison
Buy
60
DCBO
Docebo
Last Price:
$30.20
Seasonality Move:
16.2%
Sell
25
KROS
Keros Therapeutics
Last Price:
$14.51
Seasonality Move:
25.73%
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $14.48. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $14.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight selling pressure.
DCBO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.41 | Buy |
Relative Strength Index (14 RSI): | 54.63 | Buy |
Chaikin Money Flow: | -39838 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.2 - 30.76) | Buy |
Bollinger Bands (100): | (27.15 - 30.81) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.16 | Buy |
Relative Strength Index (14 RSI): | 57.96 | Buy |
Chaikin Money Flow: | -88852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.54 - 14.44) | Buy |
Bollinger Bands (100): | (11.77 - 14.67) | Buy |
DCBO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.04 | Sell |
20-day SMA: | 29.88 | Buy |
50-day SMA: | 28.17 | Buy |
200-day SMA: | 36.93 | Sell |
8-day EMA: | 6.71 | Buy |
20-day EMA: | 2.87 | Buy |
50-day EMA: | 1.18 | Buy |
200-day EMA: | 0.3 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.19 | Buy |
20-day SMA: | 14.1 | Buy |
50-day SMA: | 14.06 | Buy |
200-day SMA: | 23.9 | Sell |
8-day EMA: | 3.22 | Buy |
20-day EMA: | 1.38 | Buy |
50-day EMA: | 0.57 | Buy |
200-day EMA: | 0.14 | Buy |
Docebo Earnings Growth & DCBO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.12 per share, and an increase next year of $0.39 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.06 per share, an increase this year of $4.51 per share, and a decrease next year of $4.41 per share.
Docebo Technical Analysis
Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |